María Asunción
Gómez Muñoz
Instituto de Biomedicina de Sevilla
Sevilla, EspañaPublicacións en colaboración con investigadores/as de Instituto de Biomedicina de Sevilla (3)
2020
-
Corrigendum to ‘CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours’ (EBioMedicine (2019) 49 (82–95), (S235239641930711X), (10.1016/j.ebiom.2019.10.041))
EBioMedicine
-
Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma”
EBioMedicine
2019
-
CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours
EBioMedicine, Vol. 49, pp. 82-95